In 1975, Georges Köhler and César Milstein, biochemists from the Medical Research Council Laboratory of Molecular Biology, published a paper in Nature about a hybridoma technology that enabled the ...

In front of a basketball court, an A-frame sign reads “monoclonal antibody site” with arrows pointing to the right. Monoclonal antibodies were a common treatment for COVID-19 early in the pandemic.

As the U.S. grapples with the lasting effects of the Covid-19 pandemic, it is important to highlight the ongoing challenges faced by the 7 million immunocompromised Americans. For them, the battle ...

Researchers at the Terasaki Institute developed a novel microfluidic biosensing platform to monitor monoclonal antibody secretion in real time. The system integrates a photonic crystal biosensor with ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

Human monoclonal antibodies (mAbs) -- highly specific, identical, infection-fighting proteins produced in large quantities in the lab in cell lines that are derived from a single antibody-producing ...

Monoclonal antibodies can block a key immune‑related protein that drives the spread of brain cell damage in Parkinson's ...

VIENNA — Nipocalimab, iscalimab, and tibulizumab, but not lusvertikimab, appear to be promising new agents for Sjögren disease that warrant further investigation, suggest the results of four separate ...

Monoclonal antibodies help your immune system recognize and attack myeloma cells. These drugs are often helpful when other therapies don’t work, you have a recurrence, or you aren’t eligible for stem ...

Scientists discover and test human antibodies with the potential to prevent and treat measles virus infection.

A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong Ye from the University of Texas San Antonio, has developed a new microfluidic-based biosensing ...